Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TAS2R46 | P59540 | 2/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8104271 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL44996 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL439067 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL732959 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL15034 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL15195848 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL2860232 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| Methane SCHEMBL1276943 | 0.96 | CA1 (0.39) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL2314693 | 0.96 | CA1 (0.39) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL17351919 | 0.96 | CA1 (0.39) | CA1CA9SMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 454 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220235176-A1 | METHOD FOR PRODUCING POLYETHER ESTER CARBONATE POLYOLS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-07-28 | — | — | US | claimed |
| EP-3760663-A1 | METHOD FOR MANUFACTURING POLYETHER ESTER CARBONATE POLYOLS | Covestro Deutschland AG (DE) | 2021-01-06 | — | — | EP | claimed |
| US-20260074195-A1 | COMPOSITION, ANODE AND BATTERY | LARGAN MEDICAL CO LTD (TW) | 2026-03-12 | — | — | US | disclosed |
| EP-4700844-A1 | ANODE COMPOSITION, ANODE AND BATTERY | Largan Precision Co. Ltd. (TW) | 2026-02-25 | — | — | EP | disclosed |
| US-12509791-B2 | Formation of organic electro-grafted films on the surface of electrically conductive or semi-conductive surfaces | ALCHIMEDICS (FR) | 2025-12-30 | — | — | US | disclosed |
| EP-4636839-A2 | COMPOSITION, ANODE AND BATTERY | Largan Precision Co. Ltd. (TW) | 2025-10-22 | — | — | EP | disclosed |
| US-12433883-B2 | Covalent modification and controlled delivery of mu opioid receptor antagonists | ALLEGHENY SINGER RESEARCH INSTITUTE (US) | 2025-10-07 | — | — | US | disclosed |
| US-20250309250-A1 | COMPOSITION, ANODE AND BATTERY | LARGAN PRECISION CO., LTD. (TW) | 2025-10-02 | — | — | US | disclosed |
| US-12338197-B2 | Process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid | UNIVERZITA PARDUBICE (CZ) | 2025-06-24 | — | — | US | disclosed |
| EP-4517876-A1 | COMPOSITION, ANODE AND BATTERY | Largan Medical Co., Ltd. (TW) | 2025-03-05 | — | — | EP | disclosed |
| CN-118908377-A | Flocculant and mud sludge dewatering and solidifying treatment process | 浙江维美环保工程科技有限公司 | 2024-11-08 | — | — | CN | disclosed |
| US-6448050-B1 | Enzyme-catalyzed modifications of macromolecules in organic solvents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2002-09-10 | — | — | US | disclosed |
| EP-1224936-A1 | PHYSICAL STRENGTH ENHANCING AGENTS AND GLYCOGEN ACCUMULATION PROMOTING AGENTS | AMATO PHARMACEUTICAL PRODUCTS, LTD. (JP) | 2002-07-24 | — | — | EP | disclosed |
| EP-1219616-A1 | PROCESS FOR THE PREPARATION OF CYCLIC LACTIC ACID OLIGOMERS | AMATO PHARMACEUTICAL PRODUCTS, LTD. (JP) | 2002-07-03 | — | — | EP | disclosed |
| WO-2002038574-A1 | DIAMIDO ALKOXIDES AS POLYMERISATION INITIATORS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2002-05-16 | — | — | WO | disclosed |
| US-6210936-B1 | Enzyme-catalyzed modifications of macromolecules in organic solvents | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2001-04-03 | — | — | US | disclosed |
| US-5347020-A | Pyrolysis of polyhydroxycarboxylic acid or halogenocarboxylic acid salt in presence of catalyst; suture materials | BOEHRINGER INGELHEIM GMBH (DE) | 1994-09-13 | — | — | US | disclosed |
| EP-0264926-B1 | PROCESS FOR THE PREPARATION AND PURIFICATION OF THERMALLY INSTABLE COMPOUNDS | BOEHRINGER INGELHEIM KG (DE) | 1992-04-08 | — | — | EP | disclosed |
| US-4990222-A | Conveying through extruder, vaporizing, drawing off and condensing; efficiency, safety | BOEHRINGER INGELHEIM KG (DE) | 1991-02-05 | — | — | US | disclosed |
| EP-0264926-A2 | Process for the preparation and purification of thermally instable compounds | BOEHRINGER INGELHEIM KG (DE) | 1988-04-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509791-B2 | Formation of organic electro-grafted films on the surface of electrically conductive or semi-conductive surfaces | HCN4, EPCAM, KCNN4 | CA1 1636/4885CA9 1225/4885SMN1; SMN2 2291/4885 |
| US-12433883-B2 | Covalent modification and controlled delivery of mu opioid receptor antagonists | OPRM1, OPRK1, OPRL1 | CA1 3033/4885CA9 3591/4885SMN1; SMN2 560/4885 |
| US-20260074195-A1 | COMPOSITION, ANODE AND BATTERY | SCN10A, SAMM50, SOD1 | CA1 208/4885CA9 448/4885SMN1; SMN2 237/4885 |
| US-12338197-B2 | Process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid | HRH2, LDHA, HCAR2 | CA1 100/4885CA9 205/4885SMN1; SMN2 4400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.